IDiyas

For the Inventor, By the Inventor

Mountain View, CA, United States of America

Bryan D Lemon

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 164(Granted Patents)


Company Filing History:

goldMedal15 out of 23 
 
Harpoon Therapeutics, Inc.
 patents
silverMedal5 out of 1,970 
 
Amgen Inc.
 patents
bronzeMedal3 out of 75 
 
Amgen Research (munich) Gmbh
 patents
4. 1 out of 9 
 
Tcr2 Therapeutics Inc.
 patents
5. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2017-2025

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):
1. 12441796 - Antibody constructs for CDH19 and CD3 (2025-10-14),
2. 12415860 - Binding moiety for conditional activation of immunoglobulin molecules (2025-09-16),
3. 12371504 - Trispecific proteins and methods of use (2025-07-29),
4. 11976125 - B cell maturation antigen binding proteins (2024-05-07),
5. 11739131 - Growth differentiation factor 15 (GDF-15) polypeptides (2023-08-29),
6. 11623958 - Single chain variable fragment CD3 binding proteins (2023-04-11),
7. 11607453 - Mesothelin binding proteins (2023-03-21),
8. 11498964 - Antibody constructs for CDH19 and CD3 (2022-11-15),
9. 11453716 - Single domain serum albumin binding protein (2022-09-27),
10. 11136403 - Trispecific proteins and methods of use (2021-10-05),
11. 11085021 - Compositions and methods for TCR reprogramming using fusion proteins (2021-08-10),
12. 10927180 - B cell maturation antigen binding proteins (2021-02-23),
13. 10849973 - Prostate specific membrane antigen binding protein (2020-12-01),
14. 10844134 - PSMA targeting trispecific proteins and methods of use (2020-11-24),
15. 10730954 - MSLN targeting trispecific proteins and methods of use (2020-08-04),

Title: The Innovative Contributions of Bryan D. Lemon in Biotechnology

Introduction

Bryan D. Lemon, based in Mountain View, CA, is an accomplished inventor recognized for his significant contributions to biotechnology. With a portfolio of 20 patents, he has focused on innovative treatments aimed at addressing various medical disorders, showcasing his impact in the field.

Latest Patents

Among his latest patents are groundbreaking advancements in cancer treatment and metabolic disorder therapies. One of his notable patents involves B cell maturation antigen binding proteins, which demonstrate improved binding affinities, enabling them to mediate the killing of cancer cells expressing B cell maturation antigen (BCMA). This innovation is complemented by pharmaceutical compositions and treatment methods for cancer and its metastasis. Another significant patent focuses on growth differentiation factor 15 (GDF-15) polypeptides. These constructs and their mutants have the potential to treat or ameliorate metabolic disorders, including type 2 diabetes, obesity, dyslipidemia, and related conditions.

Career Highlights

Throughout his career, Bryan D. Lemon has made substantial contributions while working with prominent companies in the biotechnology field. He has been a part of Harpoon Therapeutics, Inc. and Amgen Inc., where he honed his expertise and engaged in pioneering research efforts.

Collaborations

In his professional journey, Bryan has collaborated with esteemed colleagues, including Richard J. Austin and Robert B. Dubridge. These partnerships have fostered an environment of innovation and shared discovery, further enhancing the impact of his work in biotechnology.

Conclusion

Bryan D. Lemon's dedication to advancing healthcare through his inventions and patents exemplifies the spirit of innovation in the biotechnology sector. His work not only contributes to scientific understanding but also paves the way for potential life-saving treatments, showcasing the vital role inventors play in the ongoing pursuit of medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…